{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T17:30:38Z","timestamp":1776965438361,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pediatric Surgery"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1053\/jpsu.2002.36188","type":"journal-article","created":{"date-parts":[[2003,2,17]],"date-time":"2003-02-17T17:18:10Z","timestamp":1045502290000},"page":"1579-1584","source":"Crossref","is-referenced-by-count":18,"title":["MDR1 modulators improve the chemotherapy response of human hepatoblastoma to doxorubicin in vitro"],"prefix":"10.1053","volume":"37","author":[{"given":"Steven","family":"Warmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gudrun","family":"G\u00f6hring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Teichmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Geerlings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/jpsu.2002.36188_bib1","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0022-3468(91)90677-L","article-title":"The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy","volume":"26","author":"King","year":"1991","journal-title":"J Pediatr Surg"},{"key":"10.1053\/jpsu.2002.36188_bib2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-2008-1046615","article-title":"Ergebnisse der Studie HB-89 bei der Behandlung maligner epithelialer Lebertumoren des Kindesalters und Konzept eines neuen Protokolls HB-94","volume":"206","author":"Von Schweinitz","year":"1994","journal-title":"Klin P\u00e4diatr"},{"key":"10.1053\/jpsu.2002.36188_bib3","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/0022-3468(92)90564-N","article-title":"Chemotherapy can convert unresectable hepatoblastoma","volume":"27","author":"Reynolds","year":"1992","journal-title":"J Pediatr Surg"},{"key":"10.1053\/jpsu.2002.36188_bib4","first-page":"519","article-title":"Preoperative chemotherapy in hepatoblastoma","volume":"110","author":"Filler","year":"1992","journal-title":"Surgery"},{"key":"10.1053\/jpsu.2002.36188_bib5","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0022-3468(95)90762-9","article-title":"Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma","volume":"30","author":"Von Schweinitz","year":"1995","journal-title":"J Pediatr Surg"},{"key":"10.1053\/jpsu.2002.36188_bib6","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0959-8049(97)00095-6","article-title":"Efficiency and toxicity of Ifosfamide, Cisplatin and Doxorubicin in the treatment of childhood hepatoblastoma","volume":"33","author":"Von Schweinitz","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1053\/jpsu.2002.36188_bib7","first-page":"3127","article-title":"Altered expression of resistance associated genes in hepatoblastoma xenografts incorporated in mice following treatment with doxorubicin or cisplatin","volume":"18","author":"Bader","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1053\/jpsu.2002.36188_bib8","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/0959-8049(96)00057-3","article-title":"P-glycoprotein\u2014A mediator of multidrug resistance in tumor cells","volume":"6","author":"Germann","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1053\/jpsu.2002.36188_bib9","first-page":"235","article-title":"Comparative study on reversal eficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo","volume":"2","author":"Watariabe","year":"1995","journal-title":"Acta Oncol"},{"key":"10.1053\/jpsu.2002.36188_bib10","first-page":"1967","article-title":"Overcoming of vincristine resistance in P833 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil","volume":"41","author":"Tsuro","year":"1981","journal-title":"Cancer Res"},{"key":"10.1053\/jpsu.2002.36188_bib11","first-page":"935","article-title":"Circumvention of breast cancer resistance protein (BCRP)-mediated resistance to camtothecins in vitro using non-substrate drugs or the BCRP inhibitor GF 120918","volume":"7","author":"Maliepaard","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1053\/jpsu.2002.36188_bib12","first-page":"809","article-title":"Characterization of the continous cell line HepT1 derived from a human hepatoblastoma","volume":"74","author":"Pietsch","year":"1996","journal-title":"Lab Invest"},{"key":"10.1053\/jpsu.2002.36188_bib13","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/0006-2952(94)00517-P","article-title":"Allosteric regulation of [H]vinblastine binding to P-glycoprotein of MCF-7 ADR cells by dexniguldipine","volume":"49","author":"Ferry","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1053\/jpsu.2002.36188_bib14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1053\/jpsu.2002.36188_bib15","first-page":"7","article-title":"Flow cytometric assay of modulation of P-glycoprotein function in whole blood by the multidrug resistance inhibitor GG918","volume":"2","author":"Witherspoon","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1053\/jpsu.2002.36188_bib16","first-page":"4595","article-title":"In nitro and in vivo reversal of multidrug resistance by GF 120918, an acridone carboxamide derivate","volume":"53","author":"Hyafil","year":"1993","journal-title":"Cancer Res"},{"key":"10.1053\/jpsu.2002.36188_bib17","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-2141.1995.tb03312.x","article-title":"Expression of MDR1, MRP, topoisomerase II\u03b1\/\u03b2 and cyclin A in primary or relapsed states of acut lymphoblastic leukaemias","volume":"89","author":"Beck","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1053\/jpsu.2002.36188_bib18","series-title":"The Analysis of Variance","author":"Scheff\u00e9","year":"1959"},{"key":"10.1053\/jpsu.2002.36188_bib19","series-title":"Basic and clinical Biostatistics","author":"Dawson-Saunders","year":"1994"},{"key":"10.1053\/jpsu.2002.36188_bib20","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0959-8049(00)00074-5","article-title":"Pretreatment prognostic factors for children with hepatoblastoma\u2014Results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1","volume":"36","author":"Brown","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1053\/jpsu.2002.36188_bib21","first-page":"275","article-title":"Multidrug resistance in pediatric malignancies","volume":"9","author":"Chan","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1053\/jpsu.2002.36188_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00173683","article-title":"Multidrug resistance in pediatric oncology","volume":"14","author":"Kuttesch","year":"1996","journal-title":"Invest New Drugs"},{"key":"10.1053\/jpsu.2002.36188_bib23","first-page":"559","article-title":"Overexpression of multidrug resistance genes MDR1 and cMOAT in human hepatocellular carcinoma and hepatoblastoma cell lines","volume":"15","author":"Minemura","year":"1999","journal-title":"Int J Oncol"},{"key":"10.1053\/jpsu.2002.36188_bib24","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0959-8049(96)00100-1","article-title":"MDR1 gene expression in solid tumors","volume":"6","author":"Goldstein","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1053\/jpsu.2002.36188_bib25","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1200\/JCO.2001.19.3.832","article-title":"Phase I study of infusional paclitaxel in combination with the P-glycoprotein antagonist PSC 833","volume":"19","author":"Chico","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/jpsu.2002.36188_bib26","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/sj.leu.2402117","article-title":"Combined action of PSC 833 (valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia","volume":"15","author":"Visani","year":"2001","journal-title":"Leukemia"},{"key":"10.1053\/jpsu.2002.36188_bib27","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/sj.bjc.6690169","article-title":"Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918","volume":"79","author":"Wallstab","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1053\/jpsu.2002.36188_bib28","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/sj.bjc.6690791","article-title":"The acridonecarboxamide GF 120918 potently reverses P-glycoprotein-mediated resistance in human sarcoma MES-Dx5 cells","volume":"81","author":"Traunecker","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1053\/jpsu.2002.36188_bib29","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/00001813-199611000-00002","article-title":"Cremophor EL reversed multidrug resistance in vitro but not in tumor-bearing mouse models","volume":"7","author":"Watanabe","year":"1996","journal-title":"Anti Cancer Drugs"},{"key":"10.1053\/jpsu.2002.36188_bib30","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1200\/JCO.2001.19.12.2983","article-title":"Phase I\/II trial of the multidrug resistance modulator valspodar combined with cisplatin and doxorubicin in refractory ovarian cancer","volume":"19","author":"Baekelandt","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/jpsu.2002.36188_bib31","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1016\/0959-8049(95)00386-W","article-title":"Adding a reverser (verapamil) to combined chemotherapy overrides resistance in small cell lung cancer xenografts","volume":"11","author":"Arvelo","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1053\/jpsu.2002.36188_bib32","first-page":"147","article-title":"Treatment of metastatic osteosarcoma with verapamil, cyclosporine and chemotherapy. A case report","volume":"47","author":"Brach","year":"1995","journal-title":"Minerva Pediatr"},{"key":"10.1053\/jpsu.2002.36188_bib33","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/bjc.1995.169","article-title":"Continous-infusion verapamil with etoposide in relapsed or resistant pediatric cancers","volume":"71","author":"Cowie","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1053\/jpsu.2002.36188_bib34","article-title":"The role of the MDR1 gene in the clinical course and an in vivo model of human hepatoblastoma","author":"Warmann","year":"2001"},{"key":"10.1053\/jpsu.2002.36188_bib35","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2400::AID-CNCR21>3.0.CO;2-6","article-title":"Comparative activity of cisplatin, ifosfamide, doxorubicin, carboplatin and etoposide in heterotransplanted hepatoblastoma","volume":"11","author":"Fuchs","year":"1998","journal-title":"Cancer"}],"container-title":["Journal of Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346802001653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346802001653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T15:26:16Z","timestamp":1554391576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022346802001653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["S0022346802001653"],"URL":"https:\/\/doi.org\/10.1053\/jpsu.2002.36188","relation":{},"ISSN":["0022-3468"],"issn-type":[{"value":"0022-3468","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}